28 APIs to be contraindicated during pregnancy

Published: 2013-05-20 06:57:00

Updated: 2013-05-20 06:57:00

The Ministry of Food and Drug Safety (MFDS) announced Wednesday a list of 28 active pharmaceutical ingredients (APIs) that will be additionally contraindicated in pregnancy from May 24.

The 28 APIs include abiraterone, alemtuzumab, arsenic trioxide, axitinib, bendamustine, bevacizumab, cabazit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK